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E-mailAbstract—The purpose of this study was to investigate the value of quantitative assessment of enhancement in
diagnosing renal cell carcinoma (RCC) with contrast-enhanced ultrasound (CEUS). A total of 73 solid renal paren-
chymal masses underwent both conventional ultrasound and CEUS. We compared the difference in maximum
diameters on conventional ultrasound and CEUS between the benign and malignant groups. Enhancement
features derived from a time-intensity curve were also analyzed. The diameters of renal cancer were found to
be larger on CEUS than on conventional ultrasound (p , 0.05). When cutoff values of 4.74 s for washout time
and 8.52% for enhancement intensity at 60 s for diagnosing RCCs were applied, the sensitivity, specificity and
area under the receiver operating characteristic curve were 67.3%, 95.2%, 86.5% and 65.4%, 81.0%, 68.4%,
respectively. The sensitivity and specificity for these two enhancement characteristics combined as a criterion
for differentiating RCCs from benign lesions were 44.0% and 99.1%, respectively. Early washout in the area of
maximal intensity in the interior of the lesion and prolonged washout in the whole area of the lesion are specific
CEUS manifestations suggestive of RCC. (E-mail: Du_lf@163.com)  2014 World Federation for Ultrasound
in Medicine & Biology.
Key Words: Contrast-enhanced ultrasound, Quantitative analysis, Time-intensity curve, Renal cell carcinoma,
Diagnosis.
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Contrast-enhanced ultrasound (CEUS), which employs
microbubble contrast agents and complementary har-
monic pulse sequences to observe perfusion, has proven
to be helpful in the diagnosis and characterization of renal
cell carcinomas (RCCs) in many clinical studies in recent
years. The advantages of CEUS include a good safety pro-
file, simplicity, patient tolerance, lack of ionizing radiation
and real-time multiplanar imaging capability (Piscaglia
et al. 2012; Torzilli 2005). Although applications of
CEUS in renal tumors have been well developed, there
still remain controversies. For example, with respect to
the CEUS features of the lesion, some studies indicate
that early washout is suggestive of RCC, whereas others
found that the CEUS manifestation of prolonged
washout is a clue to RCC (Fan et al. 2008; Ignee et al.ddress correspondence to: Lianfang Du, Department of Ultra-
Shanghai First People’s Hospital, School of Medicine, Shanghai
g University, 100 Haining Road, 200086 Shanghai, China.
: Du_lf@163.com
13872010a; Xu 2011). This study therefore retrospectively
analyzed the CEUS imaging findings on RCCs to
evaluate their diagnostic value and to characterize the
vascular perfusion pattern of lesions.METHODS
Patients
Between February 2010 and March 2013, 73 pa-
tients (45 men and 28 women; age: 23–86 y [range],
56.36 12.2 y [mean6 standard deviation]) with 73 solid
renal parenchymal masses underwent both conventional
ultrasound (US) and CEUS. The study was approved by
the institutional review board and ethics committee of
Shanghai First People’s Hospital, and CEUS examina-
tions were conducted after written consent was received
from each patient. Patients with solid renal parenchymal
masses revealed on US were enrolled in the study. All pa-
tients with contraindications according to the guidelines
of the European Federation of Societies for Ultrasound
in Medicine and Biology (EFSUMB) (Piscaglia et al.
2012) were excluded from the study.
Fig. 1. Region of interest (ROI) definitions. Three regions of
ROIs are drawn: ROImass (green) is placed over the whole
area of the mass, ROIrefer (yellow) is set to a similar depth of
the adjacent cortex, and ROIIMAX (magenta) is defined as the
area of maximal intensity (IMAX) in the interior of the lesion.
The ROImass is color-coded with warm and cold colors to repre-
sent hyper- and hypo-echoic areas of IMAX.
1388 Ultrasound in Medicine and Biology Volume 40, Number 7, 2014Conventional ultrasound and CEUS
Both conventional US and CEUS were performed
with a commercially available ultrasound system (Acuson
Sequoia 512, Siemens, Munich, Germany) using a 4C1-S
convex array transducer (frequency range: 1–4MHz). One
of two experienced radiologists scanned the lesion using
gray-scale and color Doppler sonography first. Planes of
best visualization were selected to measure the maximum
diameters of lesions. Location, echogenicity and color
flow signals were also stored for each mass.
Then a 20G cannula was inserted into an antecubital
vein for injection of contrast agent and saline solution.
The same radiologist activated the contrast pulse se-
quencing mode (mechanical index 5 0.21–0.23) and
trained the patient to take a shallow breath or hold his
or her breath when asked. The best plane was selected
to observe both the renal mass and adjacent parenchyma.
After optimization of image quality, a dose of 1.0–1.8 mL
contrast agent (SonoVue, Bracco, Milan, Italy), which
was chosen individually depending on the weight, height
and age of the patient, was administered intravenously as
a bolus, immediately followed by a flush of 5 mL 0.9%
saline solution. The real-time video record was started
from the beginning of the injection for 2 min at least
and was stored in the DICOM format.
Imaging analysis
The maximum diameter of lesions was measured on
conventional ultrasound and CEUS images. The result of
subtracting the diameter measured on conventional ultra-
sound from that measured on CEUS was recorded as the
difference in size. On conventional ultrasonic images,
lesions were divided into hyper-echoic, iso-echoic, and
hypo-echoic types in comparison to adjacent renal paren-
chyma. Homogeneity and presence of a hypo-echoic rim
were also noted. The color flow signals were classified
into two types: rich (defined as diffuse, penetrating or
peripheral color flow signals) and poor (defined as focal
or dot-like color flow signals).
To quantify contrast enhancement, SonoLiver soft-
ware (TomTec GmbH, Munich, Germany, and Bracco
Research, Geneva, Switzerland) was used, which could
depict a time-intensity curve derived from a region of in-
terest (ROI). Further, with the SonoLiver software, the
selected ROIs can be coded by red and blue colors accord-
ing to the intensity of each pixel. Red colors indicate
hyper-enhancement in comparison to the reference area,
and conversely, blue colors represent hypo-enhancement.
With this ability, the ROIs were manually selected by
another investigator with 5 y of experience in CEUS
who was blinded to the pathologic results. The ROIs
selected in this study included: ROImass, which was placed
over the whole area of the mass; ROIrefer, which was set to
a depth similar to that of the adjacent cortex; andROIIMAX,which was defined as the area of maximal intensity
(IMAX) in the interior of the lesion (Figs. 1 and 2). All
ROIswere drawn usingmore than 200 pixels. In this study,
the enhancement intensity of each ROI was expressed in
percent of the IMAX of ROIrefer, and the IMAX of the
ROIrefer was set at 100%. In this way, errors resulting
from the baseline intensity among different lesion types
and different CEUS images were eliminated. ROIrefer
was chosen to avoid the medulla because of its enhance-
ment features of slow perfusion and hypo-enhancement,
which are hemodynamically distinct from those of the cor-
tex. Motion compensation was used to avoid the distur-
bance of tissue motion.
The enhancement features analyzed in this study
included: arrival time (AT), time to peak (TTP), washout
time (WT), IMAX and intensity at 60 s (I60) (Table 1). To
our knowledge, there is no published quantitative defini-
tion for ‘‘washout phase.’’ According to EFSUMB guide-
lines, the transition from hyper- or iso-enhancement to
hypo-enhancement is commonly referred to as the start
of ‘‘washout.’’ To quantify the timing of enhancement,
we observed that when the enhancement intensity fell
to 50%–65% of maximal intensity in quantification soft-
ware, the investigator could recognize the transition of
enhancement degree by eye; therefore, the time at which
60% of maximal intensity was registered in quantification
software was chosen as time point for the washout phase.
Fig. 2. Time-intensity curves derived from regions of interest (ROIs). Rough curves represent measured intensity data,
and smooth curves were plotted according to the perfusion model using the measured data. The green, yellow and
magenta lines correspond to renal lesion, renal parenchyma surrounding the lesion and area of maximal intensity in
the interior of the lesion, respectively.
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bubble signals in the kidneys decreased too much to
reveal the true contrast between lesion and parenchyma
after 60 s.Statistical analysis
Statistical analyses were performed using SPSS
Version 17.0 statistics software for Windows (SPSS, Chi-
cago, IL, USA). c2 and Fisher’s exact tests were used to
compare lesion characterization on conventional ultra-
sound images. An independent-sample t-test was used
to compare lesion size and enhancement features between
the benign and malignant groups. A receiver operating
characteristic curve was calculated to determine the cut-
off enhancement amount suggesting a RCC. Averaged
data are presented as means 6 standard deviations. A
two-sided p , 0.05 was considered to indicate statistical
significance.Table 1. Definition of enhancement features
Abbreviation Definition Unit
AT Time of first arrival of contrast agent s
DAT Result of subtracting AT of ROIrefer from AT of
ROImass
s
TTP Time of maximum intensity s
DTTP Result of subtracting TTP of ROIrefer from TTP
of ROIIMAX
s
WT Time of 60% of maximal intensity* s
DWT Result of subtracting WT of ROIIMAX from WT
of ROImass
s
IMAX Highest value of the curve %
DIMAX Result of subtracting IMAX of ROIrefer from
IMAX of ROIIMAX
%
I60 Enhancement intensity at 60 s %
DI60 Result of subtracting I60 of ROIrefer from I60 of
ROIIMAX
%
ROI 5 region of interest; ROIrefer 5 reference area set to a similar
depth of surrounding renal parenchyma; ROImass 5 whole area of
mass; ROIIMAX5 area of maximal intensity in the interior of the lesion.
* It was observed that when the enhancement intensity fell to 50%–
65% of maximal intensity in quantification software, the investigator
could recognize the degree of enhancement began to decrease by eye.RESULTS
Final diagnosis
A total of 73 renal masses comprising 52 renal cell
carcinomas and 21 benign lesions made up the study
group. All malignant masses were identified by patholog-
ical examination, including 46 clear cell RCCs, 4 papil-
lary RCCs and 2 chromophobe RCCs. Of the 16 renal
angiomyolipomas, 6 were diagnosed on pathological
examination and 10 by the finding of fat on computed
tomography or magnetic resonance imaging scans as
well as no lesion growth after at least 8 mo of follow-
up. Two renal abscesses were diagnosed by contrast-
enhanced magnetic resonance imaging, and lesion size
decreased after antibiotic therapy. One oncocytoma was
confirmed by pathological examination. Two hypertro-
phied columns of Bertin were diagnosed by contrast-
enhanced computed tomography and unchanged size
after 8 mo of follow-up.
Diagnostic performance of conventional ultrasound
The conventional ultrasound features of benign and
malignant renal lesions are summarized in Table 2. There
was a significant difference between the two groups in
terms of lesion echogenicity distribution, homogeneity
and presence of a hypo-echoic rim (p , 0.05). Color
flow signals did not statistically differ between the benign
and malignant groups (p . 0.05).
The diagnostic sensitivity of conventional ultra-
sound features to RCCs was 82.7%, whereas the speci-
ficity was 71.4%. The positive predictive and negative
predictive values were 87.8% and 62.5%, respectively.
Overall accuracy for conventional ultrasound alone was
79.5%.
Size comparison on conventional ultrasound and CEUS
A comparison of the results for malignant and
benign lesions is outlined in Table 3. Lesion size did
not statistically differ between the malignant and benign
Table 2. Comparison of lesion characterization on
conventional ultrasound
Malignant Benign p
Echogenicity 0.002*
Hyper-echoic 23.1% (12/52) 66.7% (14/21)
Iso-echoic 19.2% (10/52) 9.5% (2/21)
Hypo-echoic 57.7% (30/52) 23.8% (5/21)
Homogeneity 0.008*
Homogeneous 32.7% (17/52) 66.7% (14/21)
Heterogeneous 67.3% (35/52) 33.3% (7/21)
Hypo-echoic rim 0.015*
Presence 38.5% (20/52) 9.5% (2/21)
Absence 61.5% (32/52) 90.5% (19/21)
Color flow signals 0.370y
Rich 25.0% (13/52) 14.3% (3/21)
Poor 75.0% (39/52) 85.7% (18/21)
* p , 0.05 by c2 test.
y p . 0.05 by Fisher’s exact test.
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tween CEUS and conventional ultrasound were signifi-
cantly larger in the malignant groups than in the benign
groups (p , 0.05) (Fig. 3).Quantitative analysis of enhancement features
Enhancement features in the ROIs of renal masses as
well as the peripheral reference tissues are summarized in
Table 4. The area analyzed had lower DAT and DTTP
values, but higher DWT, DIMAX and DI60 values,
compared with the reference area in the malignant group
than in the benign group (all p’s , 0.05). Receiver oper-
ating characteristic curve analysis of enhancement fea-
tures for differentiation between malignant and benign
lesions revealed that cutoff values of 4.74 s for DWT
and 8.52% for DI60 had the highest accuracy in diag-
nosing RCCs. When masses for which DWT was
.4.74 s were designated as malignant lesions, the sensi-
tivity, specificity and area under the receiver operating
characteristic curve were 67.3%, 95.2% and 86.5%,
respectively. Meanwhile, when the masses for which
DI60 was .8.52% were designated as malignant lesions,
the sensitivity, specificity and area under the receiver
operating characteristic curve were 65.4%, 81.0% and
68.4%, respectively (Fig. 4). The sensitivity and speci-Table 3. Comparison of size in the benign and malignant
groups
Characteristic Malignant Benign p
Diameter on CEUS (mm) 30.4 6 9.2* 25.5 616.2 0.210
Difference in diameters (mm) 3.79 6 4.81 –0.86 6 2.74 ,0.001
CEUS 5 contrast-enhanced ultrasound.
* Values are as means 6 standard deviations.ficity of these two enhancement characteristics combined
as a criterion for differentiating RCCs from benign le-
sions were 44.0% and 99.1%, respectively.DISCUSSION
In recent years, CEUS has been reported to improve
diagnostic efficacy in renal tumors compared with con-
ventional ultrasound (Gerst et al. 2011; McArthur and
Baxter 2012; Park et al. 2005). Our results indicate that
confidence in the diagnosis of tumor malignancy,
especially specificity, is significantly improved by using
CEUS. In addition, it has been thought that the majority
of malignant renal tumors enhance more quickly than
surrounding renal parenchyma and have relative hyper-
enhancement at time to peak (Aoki et al. 2011; Ignee
et al. 2010b; Siracusano et al. 2011). Our study found
that the intensity at time to peak of malignant masses
was significantly higher than that of benign masses, a
result consistent with previous findings. However,
characterization of enhancement in the washout phase
still remains controversial. According to the definition,
values of DWT greater than zero mean earlier washout
of maximal intensity area in the interior of the lesion
than the whole area of the lesion, and values of DI60
greater than zero mean hyper-enhancement of the lesion
at 60 s. In our series, 28 lesions with DWT values
.4.74 s and DI60 values .8.52% were all proven to be
malignant tumors, including 27 clear cell carcinomas
(Fig. 5) and 1 chromophobe carcinoma, indicating that
CEUS with SonoVue and the contrast pulse sequencing
mode had higher specificity in diagnosing solid RCCs
than conventional ultrasound according to the criteria of
hyper-enhancement in the wash-out phase combined
with relative earlier washout of maximal intensity area
in the interior of the lesion than the whole area of the
lesion. In this study, the degree of enhancement of
RCCs decreased more quickly in the area of maximal in-
tensity in the interior of the lesion than in the whole area
of the lesion, whereas the whole area of the lesion ex-
hibited a prolonged washout phase compared with the
adjacent renal parenchyma. This is probably a result of
heterogeneous angiogenesis, through which oxygen and
nutrition are supplied to the tumor cells and promote their
growth (Dekel et al. 2002; Park et al. 2005).
In our study, two malignant masses were misdiag-
nosed as benign by eye before quantitative analysis for
their features of distinct boundary, uniform enhancement,
iso-enhancement at time to peak and so on. However,
their DI60 values were all above the 8.52% threshold,
indicating the possibility of malignancy. The masses
were finally proven to be clear cell RCC and papillary
RCC by histopathological examination. Nevertheless, it
is worthy of note that two angiomyolipomas and two
Fig. 3. The diameter of renal cancer appeared larger on contrast-enhanced ultrasound (CEUS) than on conventional
ultrasound. (a) Conventional ultrasound revealed a hypo-echoic lesion with a diameter of 2.9 cm (calipers). (b) The diam-
eter of the mass appeared larger on CEUS than on conventional ultrasound (3.5 cm) (calipers).
CEUS in diagnosis of renal cell carcinomas d Y. CAI et al. 1391renal abscesses had DI60 values .8.52%, indicating that
diagnostic efficacy was relatively lowwith the use of only
this criterion.
The results of this study indicate that the diameters
of renal cancer appeared larger on CEUS than on conven-
tional ultrasound. In cases of benign lesions, the changes
in diameter did not statistically differ between CEUS and
conventional ultrasound. Such results indicate microvas-Table 4. Enhancement features in the regions of interest
of the malignant and benign groups
Malignant Benign p
Arrival time (AT)
AT of ROImass (s) 12.3 6 2.89* 12.7 6 3.65 0.600
AT of ROIrefer (s) 12.5 6 2.95 12.2 6 3.49 0.762
DAT (s) –0.20 6 0.44 0.47 6 1.20 0.020y
Time to peak (TTP)
TTP of ROIIMAX (s) 21.6 6 4.86 23.4 6 7.56 0.208
TTP of ROIrefer (s) 22.2 6 5.59 21.7 6 5.21 0.737
DTTP (s) –0.65 6 1.99 1.72 6 3.90 0.001y
Washout time (WT)
WT of ROImass (s) 32.2 6 8.20 28.3 6 8.10 0.071
WT of ROIIMAX (s) 24.2 6 6.04 28.0 6 10.5 0.131
DWT (s) 8.00 6 6.47 0.32 6 3.67 ,0.001y
Maximal intensity (IMAX)
IMAX of ROIIMAX (%) 216.1 6 23.4 146.6 6 19.7 0.079
IMAX of ROIrefer (%) 126.2 6 29.8 130.6 6 37.1 0.599
DIMAX (%) 89.8 6 23.4 1.69 6 13.4 0.023y
Enhancement intensity at 60 s (I60)
I60 of ROIIMAX (%) 39.5 6 5.63 6.63 6 12.4 0.003
y
I60 of ROIrefer (%) 18.9 6 4.35 18.5 6 11.5 0.965
DI60 (%) 23.5 6 5.33 –10.1 6 4.94 ,0.001
y
ROI 5 region of interest; ROIrefer 5 reference area set to a similar
depth of surrounding renal parenchyma; ROImass 5 whole area of
mass; ROIIMAX5 area of maximal intensity in the interior of the lesion;
DAT5ATof ROImass – ATof ROIrefer;DTTP5 TTP of ROIIMAX – TTP
of ROIrefer; DWT 5 WT of ROImass – WT of ROIIMAX; DIMAX 5
IMAX of ROIIMAX – IMAX of ROIrefer; DI60 5 I60 of ROIIMAX – I60
of ROIrefer.
* Values are means 6 standard deviations.
y p , 0.05 was considered as statistical significance.cular invasion in RCCs and illustrate that CEUS provides
improvements in boundary definition (Zhang et al. 2002).
Our study had some limitations. First, large masses
are not suitable for this method, because it is difficult to
set a reference region to surrounding renal parenchyma
within the same image. Second, the numbers of papillary
RCCs, chromophobe RCCs, oncocytomas and abscesses
were still small; to further confirm their enhancement fea-
tures, a larger number of patients may be needed. Third,
the differences between the benign and malignant groups
cannot be directly observed by eye or measured on an ul-
trasound diagnostic system. Further research is required
to find a more immediately appreciable feature.Fig. 4. Receiver operating characteristic (ROC) curve illus-
trating that lesion enhancement thresholds of 4.74 s for DWT
(blue line) and 8.52% for DI60 (green line) have the highest
accuracy in diagnosing renal cell carcinoma. The areas under
the curves are 86.5% for DWT and 68.4% for DI60. The red
line is the reference line.
Fig. 5. Clear cell renal cell carcinoma on conventional ultrasound and contrast-enhanced ultrasound images. (a) Solid
renal lesion on conventional ultrasound (calipers). (b) Surrounding peritumoral vessel was observed on the color Doppler
flow image (CDFI). (c) The tumor exhibited hyper-enhancement in peak. A rim of peritumoral enhancement can be
observed (arrows). (d) Some regions inside the tumor remained hyper-enhanced at 60 s. A rim of peritumoral enhance-
ment was more obvious (arrows).
1392 Ultrasound in Medicine and Biology Volume 40, Number 7, 2014CONCLUSIONS
Early washout in the area of maximal intensity in the
interior of the lesion and prolonged washout in whole
area of the lesion are CEUS manifestations suggestive
of RCC. The combination of hyper-enhancement in the
washout phase with relative earlier washout of the
maximal intensity area in the interior of the lesion has
high specificity for diagnosing RCC.Acknowledgments—This work was supported by Grant 10411951800
from the Scientific Research Project of the Shanghai Science and Tech-
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